140 related articles for article (PubMed ID: 10987014)
1. Temozolomide for refractory anaplastic astrocytoma.
Med Lett Drugs Ther; 1999 Dec; 41(1068):123-4. PubMed ID: 10987014
[No Abstract] [Full Text] [Related]
2. Oral temozolomide approved for refractory brain tumor.
Miller JL
Am J Health Syst Pharm; 1999 Oct; 56(19):1910. PubMed ID: 10554903
[No Abstract] [Full Text] [Related]
3. Temozolomide. A new option for high-grade astrocytomas.
Schwenka J; Ignoffo RJ
Cancer Pract; 2000; 8(6):311-3. PubMed ID: 11898150
[No Abstract] [Full Text] [Related]
4. [Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse--a phase II clinical study].
Nishikawa R; Shibui S; Maruno M; Sugiyama K; Sato S; Fujimaki T; Takahashi H; Wakabayashi T; Takahashi J; Kochi M; Nakamura H; Sawamura Y; Ikeda J; Hori T; Aoki T; Matsutani M
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1279-85. PubMed ID: 16969025
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of fertility following treatment with temozolomide for a high grade astrocytoma.
Palmieri C; Brock C; Newlands ES
J Neurooncol; 2005 Jun; 73(2):185. PubMed ID: 15981111
[No Abstract] [Full Text] [Related]
6. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of anaplastic astrocytomas and glioblastomas in children by the use of temozolomide (TMZ)].
Zheludkova OG; Tarasova IS; Gorbatykh SV; Belogurova MB; Kumirova EV; Borodina ID; Prityko AG; Melikian AG; Shcherbenko OI
Vopr Onkol; 2002; 48(3):356-60. PubMed ID: 12455362
[No Abstract] [Full Text] [Related]
8. NICE verdict on Temozolomide: where next?
Brada M
Br J Cancer; 2002 Feb; 86(4):499-500. PubMed ID: 11870526
[No Abstract] [Full Text] [Related]
9. Anaplastic astrocytoma in adults.
Stupp R; Reni M; Gatta G; Mazza E; Vecht C
Crit Rev Oncol Hematol; 2007 Jul; 63(1):72-80. PubMed ID: 17478095
[TBL] [Abstract][Full Text] [Related]
10. Urticarial hypersensitivity reaction caused by temozolomide.
Pothiawala S; Hsu MY; Yang C; Kesari S; Ibrahimi OA
J Drugs Dermatol; 2010 Sep; 9(9):1142-4. PubMed ID: 20865848
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
Friedman HS
Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
[TBL] [Abstract][Full Text] [Related]
12. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
13. A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.
Neyns B; Chaskis C; Joosens E; Menten J; D'Hondt L; Branle F; Sadones J; Michotte A
Cancer Invest; 2008; 26(3):269-77. PubMed ID: 18317968
[TBL] [Abstract][Full Text] [Related]
14. Temodar offers promise for treating astrocytomas.
Armstrong T; Hancock C
Clin J Oncol Nurs; 2000; 4(4):159-60. PubMed ID: 11261095
[TBL] [Abstract][Full Text] [Related]
15. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation.
Momota H; Narita Y; Miyakita Y; Hosono A; Makimoto A; Shibui S
Pediatr Blood Cancer; 2010 Sep; 55(3):577-9. PubMed ID: 20658636
[TBL] [Abstract][Full Text] [Related]
16. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy for gliomas in children].
Sawamura Y
Nihon Rinsho; 2005 Sep; 63 Suppl 9():478-82. PubMed ID: 16201567
[No Abstract] [Full Text] [Related]
18. Disseminated salmonellosis in a patient treated with temozolomide.
Georgescu G; Isola IM; Youssef S; Adachi J; Rolston K
J Infect; 2008 Nov; 57(5):414-5. PubMed ID: 18715650
[TBL] [Abstract][Full Text] [Related]
19. Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.
Su YW; Chang MC; Chiang MF; Hsieh RK
J Neurooncol; 2005 Feb; 71(3):315-8. PubMed ID: 15735923
[TBL] [Abstract][Full Text] [Related]
20. Higher dosing of temozolomide? Regression of an anaplastic oligoastrocytoma over more than three years.
Koch D; Wick W
J Neurooncol; 2006 Apr; 77(2):219-20. PubMed ID: 16292485
[No Abstract] [Full Text] [Related]
[Next] [New Search]
